scholarly journals Studies on the Metabolic Products of a Strain of Aspergillus fumigatus (DH 413). IV. Biosynthesis of Toluquinones and Chemical Structures of New Metabolites

1970 ◽  
Vol 18 (3) ◽  
pp. 561-569 ◽  
Author(s):  
YUZURU YAMAMOTO ◽  
MIKIKO SHINYA ◽  
YASUHARU OOHATA
2012 ◽  
Vol 7 (4) ◽  
pp. 1934578X1200700 ◽  
Author(s):  
Shamil Sh. Afiyatullov ◽  
Olesya I. Zhuravleva ◽  
Alexandr S. Antonov ◽  
Anatoly I. Kalinovsky ◽  
Michail V. Pivkin ◽  
...  

A new alkaloid, fumiquinazoline K (1), and a new nordammarane triterpenoid (2), together with three known diketopiperazines (3-5) and tryptoquivaline F (6) have been isolated from a marine strain of Aspergillus fumigatus KMM 4631 associated with the soft coral Sinularia sp. Their structures were determined by HR-MS and 1D and 2D NMR. Compounds 3-5 exhibit weak cytotoxicity against cytoplasm non-specific esterase in Ehrlich carcinoma cells. Compound 3 also induces early apoptosis of the same cells in a non-toxic range of concentrations.


2011 ◽  
Vol 89 (1) ◽  
pp. 72-76 ◽  
Author(s):  
Fa-Zuo Wang ◽  
De-Hai Li ◽  
Tian-Jiao Zhu ◽  
Min Zhang ◽  
Qian-Qun Gu

Two new metabolites containing a 1-oxa-7-azaspiro[4.4]non-2-ene-4,6-dione core, pseurotin A1 (1) and A2 (2), as well as pseurotin A (3), were isolated from the holothurian-derived fungus Aspergillus fumigatus WFZ-25. These compounds were determined using extensive analysis of their spectroscopic data, including 1D and 2D NMR, HR-ESI-MS, and circular dichroism (CD) experiments.


1982 ◽  
Vol 1982 (15) ◽  
pp. 13-15
Author(s):  
T. YOSHIZAWA ◽  
T. SAKAMOTO ◽  
Y. AYANO ◽  
C.J. MIROCHA

1965 ◽  
Vol 13 (8) ◽  
pp. 1009-1011 ◽  
Author(s):  
Yuzuru Yamamoto ◽  
Keiichi Nitta ◽  
Yoshie Terashima ◽  
Jitsukazu Ishikawa ◽  
Nobuo Watanabe

Marine Drugs ◽  
2021 ◽  
Vol 19 (12) ◽  
pp. 656
Author(s):  
Vincent Hort ◽  
Eric Abadie ◽  
Nathalie Arnich ◽  
Marie-Yasmine Dechraoui Bottein ◽  
Zouher Amzil

In recent decades, more than 130 potentially toxic metabolites originating from dinoflagellate species belonging to the genus Karenia or metabolized by marine organisms have been described. These metabolites include the well-known and large group of brevetoxins (BTXs), responsible for foodborne neurotoxic shellfish poisoning (NSP) and airborne respiratory symptoms in humans. Karenia spp. also produce brevenal, brevisamide and metabolites belonging to the hemi-brevetoxin, brevisin, tamulamide, gymnocin, gymnodimine, brevisulcenal and brevisulcatic acid groups. In this review, we summarize the available knowledge in the literature since 1977 on these various identified metabolites, whether they are produced directly by the producer organisms or biotransformed in marine organisms. Their structures and physicochemical properties are presented and discussed. Among future avenues of research, we highlight the need for more toxin occurrence data with analytical techniques, which can specifically determine the analogs present in samples. New metabolites have yet to be fully described, especially the groups of metabolites discovered in the last two decades (e.g tamulamides). Lastly, this work clarifies the different nomenclatures used in the literature and should help to harmonize practices in the future.


1977 ◽  
Vol 23 (9) ◽  
pp. 1140-1144 ◽  
Author(s):  
Fumiki Yoshizako ◽  
Mitsuo Chubachi ◽  
Atsuo Nishimura ◽  
Teruo Ueno

Aspergillus fumigatus ATCC 28282 converted phenylacetic acid into a new dihydroxylated compound (2,6-dihydroxyphenylacetic acid) which was identified as 2,6-dimethoxyphenylacetic acid methyl ester. Two other new metabolites have been isolated also and identified as ortho- hydroxyphenylacetic acid and meta-hydroxyphenylacetic acid.


Marine Drugs ◽  
2018 ◽  
Vol 16 (11) ◽  
pp. 437 ◽  
Author(s):  
Xiaxia Di ◽  
Caroline Rouger ◽  
Ingibjorg Hardardottir ◽  
Jona Freysdottir ◽  
Tadeusz Molinski ◽  
...  

An UPLC-qTOF-MS-based dereplication study led to the targeted isolation of seven bromoindole alkaloids from the sub-Arctic sponge Geodia barretti. This includes three new metabolites, namely geobarrettin A–C (1–3) and four known compounds, barettin (4), 8,9-dihydrobarettin (5), 6-bromoconicamin (6), and l-6-bromohypaphorine (7). The chemical structures of compounds 1–7 were elucidated by extensive analysis of the NMR and HRESIMS data. The absolute stereochemistry of geobarrettin A (1) was assigned by ECD analysis and Marfey’s method employing the new reagent l-Nα-(1-fluoro-2,4-dinitrophenyl)tryptophanamide (l-FDTA). The isolated compounds were screened for anti-inflammatory activity using human dendritic cells (DCs). Both 2 and 3 reduced DC secretion of IL-12p40, but 3 concomitantly increased IL-10 production. Maturing DCs treated with 2 or 3 before co-culturing with allogeneic CD4+ T cells decreased T cell secretion of IFN-γ, indicating a reduction in Th1 differentiation. Although barettin (4) reduced DC secretion of IL-12p40 and IL-10 (IC50 values 11.8 and 21.0 μM for IL-10 and IL-12p40, respectively), maturing DCs in the presence of 4 did not affect the ability of T cells to secrete IFN-γ or IL-17, but reduced their secretion of IL-10. These results indicate that 2 and 3 may be useful for the treatment of inflammation, mainly of the Th1 type.


Sign in / Sign up

Export Citation Format

Share Document